Rhumbline Advisers Elanco Animal Health Inc Transaction History

Rhumbline Advisers

$121 Billion
Q3 2025

A detailed history of Rhumbline Advisers transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Rhumbline Advisers holds 1,319,770 shares of ELAN stock, worth $27.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,319,770

Previous 454,350 190.47%

Holding current value

$27.8 Million

Previous $6.49 Million 309.68%

% of portfolio

0.02%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$13.68 - $20.14 $11.8 Million - $17.4 Million	865,420 Added 190.47%	1,319,770 $26.6 Million
Q2 2025 Aug 12, 2025	SELL	$8.1 - $14.3 $163,101 - $287,944	-20,136 Reduced 4.24%	454,350 $6.49 Million
Q1 2025 Apr 08, 2025	SELL	$10.04 - $12.47 $69,798 - $86,691	-6,952 Reduced 1.44%	474,486 $4.98 Million
Q4 2024 May 29, 2025	BUY	$11.63 - $14.67 $80,851 - $101,985	6,952 Added 1.47%	481,438 $5.83 Million
Q4 2024 Jan 30, 2025	BUY	$11.63 - $14.67 $25,690 - $32,406	2,209 Added 0.46%	481,438 $5.83 Million

Q3 2024 Nov 12, 2024	SELL	$11.85 - $15.47 $21,804 - $28,464	-1,840 Reduced 0.38%	479,229 $7.04 Million
Q2 2024 Aug 01, 2024	SELL	$12.93 - $18.45 $195,592 - $279,093	-15,127 Reduced 3.05%	481,069 $6.94 Million
Q1 2024 May 09, 2024	SELL	$14.37 - $16.46 $985,408 - $1.13 Million	-68,574 Reduced 12.14%	496,196 $8.08 Million
Q4 2023 Feb 08, 2024	BUY	$8.6 - $14.94 $22,016 - $38,246	2,560 Added 0.46%	564,770 $8.42 Million
Q3 2023 Nov 09, 2023	SELL	$9.81 - $12.62 $13,792 - $17,743	-1,406 Reduced 0.25%	562,210 $6.32 Million
Q2 2023 Aug 08, 2023	BUY	$8.08 - $10.37 $669,347 - $859,050	82,840 Added 17.23%	563,616 $5.67 Million
Q1 2023 May 11, 2023	SELL	$8.79 - $14.58 $82,406 - $136,687	-9,375 Reduced 1.91%	480,776 $4.52 Million
Q4 2022 Feb 14, 2023	BUY	$11.49 - $13.65 $271,508 - $322,549	23,630 Added 5.07%	490,151 $5.99 Million
Q3 2022 Nov 10, 2022	BUY	$12.41 - $32.42 $292,416 - $763,912	23,563 Added 5.32%	466,521 $5.79 Million
Q2 2022 Aug 11, 2022	BUY	$19.63 - $26.62 $1.34 Million - $1.82 Million	68,239 Added 18.21%	442,958 $8.7 Million
Q1 2022 May 12, 2022	BUY	$24.65 - $29.0 $453,239 - $533,223	18,387 Added 5.16%	374,719 $9.78 Million
Q4 2021 Feb 10, 2022	BUY	$27.74 - $34.09 $300,340 - $369,092	10,827 Added 3.13%	356,332 $10.1 Million
Q3 2021 Nov 12, 2021	SELL	$29.2 - $36.72 $956,708 - $1.2 Million	-32,764 Reduced 8.66%	345,505 $11 Million
Q2 2021 Aug 05, 2021	SELL	$28.76 - $35.98 $653,024 - $816,961	-22,706 Reduced 5.66%	378,269 $13.1 Million
Q1 2021 May 06, 2021	SELL	$27.85 - $34.49 $961,493 - $1.19 Million	-34,524 Reduced 7.93%	400,975 $11.8 Million
Q4 2020 Feb 10, 2021	BUY	$27.53 - $33.79 $1.52 Million - $1.86 Million	55,059 Added 14.47%	435,499 $13.4 Million
Q3 2020 Nov 12, 2020	SELL	$21.1 - $29.13 $649,373 - $896,504	-30,776 Reduced 7.48%	380,440 $10.6 Million
Q2 2020 Aug 13, 2020	BUY	$18.94 - $24.93 $228,681 - $301,004	12,074 Added 3.02%	411,216 $8.82 Million
Q1 2020 May 06, 2020	BUY	$16.68 - $32.25 $830,230 - $1.61 Million	49,774 Added 14.25%	399,142 $8.94 Million
Q4 2019 Feb 05, 2020	BUY	$25.29 - $29.45 $157,759 - $183,709	6,238 Added 1.82%	349,368 $10.3 Million
Q3 2019 Oct 23, 2019	BUY	$25.62 - $34.96 $267,472 - $364,982	10,440 Added 3.14%	343,130 $9.12 Million
Q2 2019 Aug 14, 2019	BUY	$31.11 - $34.79 $1.16 Million - $1.3 Million	37,389 Added 12.66%	332,690 $11.2 Million
Q1 2019 May 01, 2019	BUY	$29.0 - $32.83 $6.57 Million - $7.44 Million	226,516 Added 329.31%	295,301 $9.47 Million
Q4 2018 Jan 31, 2019	BUY	$29.63 - $34.5 $2.04 Million - $2.37 Million	68,785 New	68,785 $2.17 Million

Others Institutions Holding ELAN

# of Institutions

460

Shares Held

491M

Call Options Held

780K

Put Options Held

1.08M

View Full List

About Elanco Animal Health Inc

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $10B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

More about ELAN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Elanco Animal Health Inc Transaction History